Cargando…
Cost-Effectiveness of the First Line Treatment Options For Metastatic Renal Cell Carcinoma in India
Tyrosine kinase inhibitors such as sunitinib and pazopanib are the mainstay of treatment of metastatic renal cell carcinoma (mRCC) in India. However, pembrolizumab and nivolumab have shown significant improvement in the median progression-free survival and overall survival among patients with mRCC....
Autores principales: | Gupta, Dharna, Singh, Ashish, Gupta, Nidhi, Mehra, Nikita, Bahuguna, Pankaj, Aggarwal, Vipul, Krishnamurthy, Manjunath Nookala, Roy, Partha Sarathi, Malhotra, Pankaj, Gupta, Sudeep, Kumar, Lalit, Kataki, Amal, Prinja, Shankar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166401/ https://www.ncbi.nlm.nih.gov/pubmed/36795991 http://dx.doi.org/10.1200/GO.22.00246 |
Ejemplares similares
-
Financial toxicity of cancer treatment in India: towards closing the cancer care gap
por: Prinja, Shankar, et al.
Publicado: (2023) -
Development of National Cancer Database for Cost and Quality of Life (CaDCQoL) in India: a protocol
por: Prinja, Shankar, et al.
Publicado: (2021) -
Cost Effectiveness of Bevacizumab Plus Chemotherapy for the Treatment of Advanced and Metastatic Cervical Cancer in India—A Model-Based Economic Analysis
por: Gupta, Nidhi, et al.
Publicado: (2022) -
Cost-effectiveness analysis of different combination therapies for the treatment of chronic lymphocytic leukaemia in India
por: Nehra, Prerika, et al.
Publicado: (2023) -
Cost-Effectiveness of Temozolamide for Treatment of Glioblastoma Multiforme in India
por: Gupta, Nidhi, et al.
Publicado: (2021)